Q1 2020 Redhill Biopharma Ltd Earnings Call Transcript
Good day, and welcome to the RedHill Biopharma's First Quarter 2020 Financial Results Conference Call. At this time, I would like to introduce the conference call RedHill's CEO, Mr. Dror Ben-Asher; Mr. Micha Ben-Chorin, RedHill's Chief Financial Officer; Mr. Rick Scruggs, RedHill's Chief Commercial Officer; and Mr. Gilead Raday, RedHill's Chief Operating Officer.
Before we begin, we will read from RedHill's safe harbor statement. Please go ahead.
This conference call may contain projections or other forward-looking statements regarding future events or the future performance of RedHill, including statements with respect to RedHill's expectations regarding the business, promotion and other efforts related to RedHill's commercialization activities and the initiation, timing, progress and results of RedHill's research manufacturing preclinical studies, clinical trials, marketing applications and approvals, if any, including RedHill's activities regarding its therapeutic candidates opaganib and RHB-107 as a potential treatment
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |